Abiopharma

News list

Tardiff Daniel 🔴 sold 1.7K shares of Camp4 Therapeutics Corp (CAMP) at $4.76 Transaction Date: Aug 19, 2026 | Filing ID: 058107

Full text

News bot Aug. 20, 2026, 12:46 a.m.
🔍 Tardiff Daniel (Executive)

Company: Camp4 Therapeutics Corp (CAMP)

Report Date: 2026-08-19
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares sold: 1,738
Detailed Transactions and Holdings:
- Sold 1,738 shares of Common Stock at $4.76 per share (Direct)
  Date: 2026-08-19 | Code: S | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: The shares sold were previously acquired by the reporting person pursuant to the CAMP4 Therapeutics Corporation Employee Stock Purchase Plan (the "ESPP") for the purchase period of January 1, 2026 through June 30, 2026 in a transaction that was exempt under Rule 16b-3(c).